3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
11
Burkitt Lymphoma
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Neoplasm Metastasis
1
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Leukemia, Biphenotypic, Acute
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Cyclophosphamide
6
fludarabine phosphate
5
fludarabine
5
Whole-Body Irradiation
4
Busulfan
4
Biopsy
4
Specimen Handling
3
Injections
3
Cytarabine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Tacrolimus
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Cyclosporine
2
CPX-351
2
Azacitidine
2
treosulfan
1
peginterferon alfa-2b
1
olutasidenib
1
itacitinib
1
canakinumab
1
aldesleukin
1
X-Rays
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
dexamethasone 21-phosphate
×
30 days
×
Clear all
No trials found.